Testosterone injections are made from plant-derived raw materials, primarily compounds extracted from soybeans and wild yams. The testosterone molecule in your injection is chemically identical to what your body produces naturally, but it starts its life as a plant sterol that gets transformed through a series of chemical and biological steps in a pharmaceutical manufacturing facility.
The Plant Starting Materials
The two main sources of raw material for testosterone manufacturing are soybean phytosterols and a compound called diosgenin found in wild yams (specifically species in the Dioscorea family). Soybean phytosterol is a mixture of several plant sterols, with the most abundant being beta-sitosterol (about 42%), stigmasterol (26%), and campesterol (23%). These sterols share a molecular backbone with testosterone, which makes it possible to convert one into the other.
Diosgenin, the yam-derived compound, has been a cornerstone of steroid manufacturing since the 1940s. It was first isolated from a Japanese yam species in the 1930s, and its usefulness in making hormones was pioneered by a chemist named Russell Marker at Penn State. Before plant sources were developed, the only option for producing steroid hormones involved extracting them from animal urine, including urine from pregnant cows and mares. Plant-based synthesis made large-scale, affordable production possible for the first time.
How Plants Become Testosterone
The conversion from plant sterol to testosterone involves stripping away and rearranging parts of the molecule’s structure. Russell Marker developed the key technique in the early 1940s, now called the Marker Degradation. This chemical process removes a large side chain from the plant sterol molecule, leaving behind a structure that closely resembles progesterone. From progesterone, further chemical modifications to the ring structure yield testosterone. George Rosenkranz, working with Marker’s chemistry, extended the process from diosgenin to produce testosterone and other steroid hormones.
Modern manufacturing also uses a biological approach. Specialized bacteria (strains of Mycolicibacterium neoaurum) can convert cheap soybean phytosterols directly into testosterone through a fermentation process. This “bioconversion” method uses living organisms to do the chemical heavy lifting, offering an alternative to purely synthetic chemistry. In both cases, the end product is the same molecule your body makes on its own.
Why Esters Are Added
Pure testosterone, if injected, would be absorbed and broken down by your body almost immediately. To make injections practical, manufacturers chemically attach a fatty acid chain to the testosterone molecule. This creates what’s called a testosterone ester. The two most common versions are testosterone cypionate and testosterone enanthate, each named for the specific fatty acid used.
The ester makes testosterone more oil-soluble, which is critical because the injection is suspended in an oil carrier. Once injected into muscle tissue, the oily depot slowly releases the testosterone ester into surrounding fluid. Your body’s enzymes then clip off the fatty acid chain, freeing active testosterone into your bloodstream. The length of the attached fatty acid chain determines how slowly this release happens, which is why different esters have different injection schedules. Longer chains mean slower release and less frequent injections.
What Else Is in the Injection
A testosterone injection isn’t just testosterone ester dissolved in oil. The formulation includes a few other ingredients, each with a specific purpose. Pfizer’s testosterone cypionate injection, for example, contains cottonseed oil as the carrier (560 to 736 mg per mL depending on concentration) and benzyl alcohol (about 9.45 mg per mL) as a preservative. Some manufacturers use sesame oil instead of cottonseed oil, which matters if you have a seed oil allergy.
The oil serves as the depot, holding the testosterone ester in place at the injection site and controlling how quickly it enters your system. The preservative prevents bacterial growth in multi-dose vials. The final product is a clear, yellowish, oily liquid.
Manufacturing and Quality Controls
The raw testosterone powder used in injections is classified as an active pharmaceutical ingredient, or API. It appears as a white or creamy white crystalline powder before being dissolved into the oil formulation. Manufacturers produce this powder under strict guidelines called current Good Manufacturing Practices, and every batch is tested against specifications that verify its identity, strength, purity, and quality both at release and throughout its shelf life.
The United States Pharmacopeia sets the benchmark standards that the powder must meet. These specifications ensure that the testosterone cypionate or enanthate in your vial is the correct molecule at the correct concentration, free of dangerous impurities. The FDA reviews and approves the entire supply chain, from the facility producing the raw powder to the final injectable product. Most of the API manufacturing happens at specialized pharmaceutical chemistry facilities, with significant production based in countries with large-scale steroid synthesis infrastructure.
From Animal Urine to Soybeans
The history of where testosterone comes from tracks a fascinating shift. In the 1930s, researchers first identified the structures of sex hormones and began using them medically. Early production relied on animal sources. In 1936, the pharmaceutical company Parke-Davis sent Russell Marker a steroid extract from the urine of pregnant cows and mares, from which he isolated a precursor and converted it into 35 grams of progesterone, the largest amount ever produced in a single batch at that time.
Marker’s breakthrough with Mexican wild yams changed everything. By finding an abundant plant source and developing a practical method to convert it, he laid the foundation for an entire steroid hormone industry based in Mexico. Today, virtually all commercial testosterone starts from plant materials. The chemistry has been refined over eight decades, but the core insight remains the same: plant sterols and human hormones share enough molecular architecture that one can be efficiently transformed into the other.